Korean J Clin Neurophysiol.  2013 Dec;15(2):77-79. 10.14253/kjcn.2013.15.2.77.

Acute Exacerbation of Interstitial Lung Disease in Newly Diagnosed Probable Dermatomyositis

• Ji KH
• Kim YJ
• Seo JH
• Kim OK
• Chung EJ
• Bae JS

• KMID: 1863280
• DOI: http://doi.org/10.14253/kjcn.2013.15.2.77

Abstract

No abstract available.

Keyword

Dermatomyositis; Pneumonia; Interstitial lung disease

MeSH Terms

Dermatomyositis*
Lung Diseases, Interstitial*
Pneumonia

Figure

• 

  Figure 1. Initial chest X-ray (A) shows no active lung lesion. After 1 month of follow-up, chest X-ray (B) shows ground glass opacities in both lung. High resolution CT (C, D) shows interstitial septal thickening with geographic pattern of ground glass opacity and consolidation.

Reference

1.Fathi M., Dastmalchi M., Rasmussen E., Lundberg IE., Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004. 63:297–301.

2.Rose AL., Walton JN. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 1966. 89:747–768.

3.Suda T., Kaida Y., Nakamura Y., Enomoto N., Fujisawa T., Imokawa S, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 2009. 103:846–853.

4.Chen IJ., Tsai WP., Wu YJ., Luo SF., Ho HH., Liou LB, et al. Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford). 2010. 49:2429–2437.

5.Choy EH., Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford). 2002. 41:7–13.

6.Kalluri M., Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med. 2010. 31:501–512.

7.Scott DL., Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006. 355:704–712.